Cargando…
Leflunomide for BKvirus: Report of Seven Kidney-Transplanted Children
BACKGROUND: Leflunomide is an immunosuppressive agent commercialized for treatment of rheumatoid arthritis. Because of its immunosuppressive and possible antiviral properties, leflunomide has been evaluated in some case series of BKVAN with favorable results, mostly in adult patients. Leflunomide ta...
Autores principales: | Launay, M., Baudouin, V., Guillemain, R., Maisin, A., Flodrops, H., Douez, E., Mavoungou, S., Jullien, V., Billaud, E. M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Avicenna Organ Transplantation Institute
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6409091/ https://www.ncbi.nlm.nih.gov/pubmed/30863521 |
Ejemplares similares
-
IL28B rs12979860 genotype as a predictor marker of progression to BKVirus Associated nephropathy, after kidney transplantation
por: Dvir, Roee, et al.
Publicado: (2017) -
Influence of Renal Function and Age on the Pharmacokinetics of Levofloxacin in Patients with Bone and Joint Infections
por: Eloy, Gauthier, et al.
Publicado: (2020) -
Leflunomide therapy for IgA vasculitis with nephritis in children
por: Hou, Ling, et al.
Publicado: (2021) -
Leflunomide-Induced Hidradenitis Suppurativa
por: Machan, Achraf, et al.
Publicado: (2020) -
Use of Leflunomide as an Antiviral Agent with Everolimus for BK Virus Nephropathy Patients After Kidney Transplantation: A Case Series
por: Yamazaki, Tomotaka, et al.
Publicado: (2020)